NCT00935961 2013-08-09RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck CancerMemorial Sloan Kettering Cancer CenterPhase 1 Completed18 enrolled